Search Results

LDN193189 2 mg  | 99.11%

TargetMol

LDN193189 (DM 3189) is a selective BMP signaling inhibitor, inhibiting the transcriptional activity of ALK2 and ALK3 (IC50s: 0.8/0.8/5.3/16.7 nM for ALK1/2/3/6).

More Information Supplier Page

×

LDN193189

LDN193189 10 mg  | 99.11%

TargetMol

LDN193189 (DM 3189) is a selective BMP signaling inhibitor, inhibiting the transcriptional activity of ALK2 and ALK3 (IC50s: 0.8/0.8/5.3/16.7 nM for ALK1/2/3/6).

More Information Supplier Page

×

LDN193189

Ceritinib 50 mg  | 99.46%

TargetMol

Ceritinib (LDK378) is a specific ALK inhibitor (IC50: 0.2 nM).

More Information Supplier Page

×

Ceritinib

BLU9931 10 mg  | 96.33%

TargetMol

BLU9931 is the first selective small molecule inhibitor of FGFR4.

More Information Supplier Page

×

BLU9931

BLU9931 25 mg  | 96.33%

TargetMol

BLU9931 is the first selective small molecule inhibitor of FGFR4.

More Information Supplier Page

×

BLU9931

BLU9931 50 mg  | 96.33%

TargetMol

BLU9931 is the first selective small molecule inhibitor of FGFR4.

More Information Supplier Page

×

BLU9931

BLU9931 5 mg  | 96.33%

TargetMol

BLU9931 is the first selective small molecule inhibitor of FGFR4.

More Information Supplier Page

×

BLU9931

SC144 10 mg  | Purity Not Available

TargetMol

SC144 is an orally active small-molecule gp130 inhibitor.

More Information Supplier Page

×

SC144

SC144 25 mg  | Purity Not Available

TargetMol

SC144 is an orally active small-molecule gp130 inhibitor.

More Information Supplier Page

×

SC144

SC144 50 mg  | Purity Not Available

TargetMol

SC144 is an orally active small-molecule gp130 inhibitor.

More Information Supplier Page

×

SC144